(Q81757857)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688241%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Antibody-drug conjugates ace the tolerability test (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688241%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Nitin K Damle

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688241%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 August 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688241%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688241%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688241%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688241%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

884-885

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688241%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nbt0808-884

11 January 2020

exact match

0 references

cites work

Antibody-drug conjugates for cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FNBT0808-884

7 January 2021

Arming antibodies: prospects and challenges for immunoconjugates

1 reference

https://api.crossref.org/works/10.1038%2FNBT0808-884

7 January 2021

Drug-conjugated monoclonal antibodies for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FNBT0808-884

7 January 2021

Tumour-targeted chemotherapy with immunoconjugates of calicheamicin

1 reference

https://api.crossref.org/works/10.1038%2FNBT0808-884

7 January 2021

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0808-884

7 January 2021

Reduction-alkylation strategies for the modification of specific monoclonal antibody disulfides

1 reference

https://api.crossref.org/works/10.1038%2FNBT0808-884

7 January 2021

Engineered antibody-drug conjugates with defined sites and stoichiometries of drug attachment.

1 reference

https://api.crossref.org/works/10.1038%2FNBT0808-884

7 January 2021

Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate

1 reference

https://api.crossref.org/works/10.1038%2FNBT0808-884

7 January 2021

Identifiers

DOI

10.1038/NBT0808-884

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18688241%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference